Skip to Content

Rule

Egg Safety; Final Rule for Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation; Public Meetings

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice of public meetings.

The Food and Drug Administration (FDA) is announcing two public meetings to discuss the final rule concerning the prevention of Salmonella Enteritidis (SE) in shell eggs during production, storage, and transportation. The purpose of the public meetings is to explain the requirements of the rule and how to comply with it, and to provide the public an opportunity to ask questions.

Dates, Times, and Locations:

See “How to Participate in the Meetings” in the SUPPLEMENTARY INFORMATION section of this document for dates and times of the meetings, closing dates for advance registration, requesting special accommodations due to disability, and other information regarding meeting participation.

Start Further Info

Contact Person:

For general questions about the meetings or for special accommodations due to a disability, contact Juanita Yates, Center for Food Safety and Applied Nutrition (HFS-009), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301-436-1731, e-mail: juanita.yates@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

I. How to Participate in the Meetings

Table 1 of this document provides information on participation in the meetings.

Table 1.

DateAddressElectronic AddressOther Information
First public meetingSeptember 30, 2009, from 1 p.m. to 5 p.m.Hyatt Regency Chicago, 151 East Wacker Dr., Chicago, IL 60601
Advance registrationBy September 21, 2009We encourage you to use electronic registration if possible.1http://www.fda.gov/​Food/​NewsEvents/​WorkshopsMeetingsConferences/​default.htmThere is no registration fee for the public meetings. Early registration is recommended because seating is limited.
Request special accommodations due to a disabilityBy September 21, 2009See Contact Person
Start Printed Page 44751
Second public meetingNovember 5, 2009, from 1 p.m. to 5 p.m.The Westin Peachtree Plaza Hotel, 210 Peachtree St., NW., Atlanta, GA 30303
Advance registrationBy October 26, 2009We encourage you to use electronic registration if possible.1http://www.fda.gov/​Food/​NewsEvents/​WorkshopsMeetingsConferences/​default.htmThere is no registration fee for the public meetings. Early registration is recommended because seating is limited.
Request special accommodations due to a disabilityBy October 26, 2009See Contact Person
1 You may also register via e-mail, mail, or fax. Please include your name, title, firm name, address, and phone and fax numbers in your registration information and send to: Deborah Harris, EDJ Associates, Inc., 11300 Rockville Pike, suite 1001, Rockville, MD 20852, 240-221-4326, FAX: 301-945-4295, e-mail: fda-CFSAN_Registration@edjassociates.com. Onsite registration will also be available at both meeting sites.

II. Background

In the Federal Register of July 9, 2009 (74 FR 33030), FDA published a final rule, “Prevention of Salmonella Enteritidis in Shell Eggs During Production, Storage, and Transportation,” that requires shell egg producers to implement measures to prevent SE from contaminating eggs on the farm and from further growth during storage and transportation, and requires these producers to maintain records concerning their compliance with the rule and to register with FDA. FDA took this action because SE is among the leading bacterial causes of foodborne illness in the United States, and shell eggs are a primary source of human SE infections. The final rule will reduce SE-associated illnesses and deaths by reducing the risk that shell eggs are contaminated with SE.

This document announces two public meetings as part of the agency's planned outreach initiatives regarding the final rule.

III. Transcripts

Please be advised that as soon as a transcript is available, it will be accessible at http://www.regulations.gov. It may be viewed at the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A transcript will also be available in either hardcopy or on CD-ROM, after submission of a Freedom of Information request. Written requests are to be sent to Division of Freedom of Information (HFI-35), Office of Management Programs, Food and Drug Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 20857.

Start Signature

Dated: August 24, 2009.

David Horowitz,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. E9-20856 Filed 8-28-09; 8:45 am]

BILLING CODE 4160-01-S